drugset / Trial / NCT02035111

A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.

NCT02035111 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and the efficacy of Tianshu capsule treating Migraine Headache.

Timeline

Start
2014-03
Primary completion
2015-04
Completion
2015-11

Outcome

Met primary endpoint

paper Following the 12-week treatment, significant improvement was observed in the TSC group concerning both primary and secondary outcomes. PMID 31842860 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Tianshu capsule Traditional medicine (herbal / TCM) 1.36 g Oral

Indications